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Abstract
Background: We examined the quality of adult epilepsy care using the Quality Indicators in Epilepsy Treatment
(QUIET) measure, and variations in quality based on the source of epilepsy care.
Methods: We identified 311 individuals with epilepsy diagnosis between 2004 and 2007 in a tertiary medical
center in New England. We abstracted medical charts to identify the extent to which participants received quality
indicator (QI) concordant care for individual QI’s and the proportion of recommended care processes completed
for different aspects of epilepsy care over a two year period. Finally, we compared the proportion of
recommended care processes completed for those receiving care only in primary care, neurology clinics, or care
shared between primary care and neurology providers.
Results: The mean proportion of concordant care by indicator was 55.6 (standard deviation = 31.5). Of the 1985
possible care processes, 877 (44.2%) were performed; care specific to women had the lowest concordance (37% vs.
42% [first seizure evaluation], 44% [initial epilepsy treatment], 45% [chronic care]). Individuals receiving shared care
had more aspects of QI concordant care performed than did those receiving neurology care for initial treatment
(53% vs. 43%; X
2 = 9.0; p = 0.01) and chronic epilepsy care (55% vs. 42%; X
2 = 30.2; p < 0.001).
Conclusions: Similar to most other chronic diseases, less than half of recommended care processes were
performed. Further investigation is needed to understand whether a shared-care model enhances quality of care,
and if so, how it leads to improvements in quality.
Background
While existing quality indicators have focused on a
number of highly prevalent chronic conditions (e.g., dia-
betes, hypertension) they do not address the quality of
care for less prevalent, but serious conditions, such as
epilepsy. Epilepsy care presents complexity in the sense
that providers must balance seizure control, adverse
drug effects, and complicated issues associated with
epilepsy itself (e.g. mood disorders [1-3]) while also
being mindful of consequences related to long-term
treatment with antiepileptic drugs (e.g. bone health
[4-6]). Thus, it is important to begin examining the
quality of care provided to patients with epilepsy using
quality measures and identifying gaps in quality of care.
The United Kingdom has begun this process [7] due to
the availability of not only clinical guidelines for care for
patients with epilepsy[8,9], but also quality indicators
from the Quality and Outcomes Framework [7]. While
no comprehensive national guidelines for care of
patients with epilepsy exist in the United States, the
development of the QUality Indicators for Epilepsy
Treatment in adults (QUIET) allows us to begin to
examine the quality of epilepsy care in the United
States.
The purpose of this study is to describe the quality of
care received by adults with epilepsy in a major medical
center in a Northeastern US city using the QUIET indi-
cators-quality indicators developed as part of a larger
s t u d yf u n d e db yt h eC e n t e r sf o rD i s e a s eC o n t r o la n d
Prevention (CDC; Additional file 1)-and to assess the
quality of epilepsy care in primary care and general neu-
rology settings. Similar to other countries, in the US a
substantial number of patients continue to receive their
epilepsy care solely within the context of primary care
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other chronic diseases have found better quality of care
among patients receiving care from medical sub-specia-
lists or within a shared care context [11-13]. Thus, we
examine the extent to which variations exist in quality
of care among patients who received epilepsy care only
within primary care, only within neurology subspecialty
care, and within both neurology and primary care
(shared). Based on findings from previous studies, we
hypothesize that patients with epilepsy are more likely
to receive high quality care when they receive specialty
care exclusively or have epilepsy care shared by both
primary care and neurology specialty care [14-16].
Methods
Data
Data from the electronic medical record of a single
medical center in the northeastern United States were
used in this study to identify patients with epilepsy and
assess the extent to which recommended processes of
care were performed. The electronic medical record
includes templates for certain aspects of care such as
vital signs, medications, and lab tests. However, as pro-
gress notes are not disease specific or used for examin-
ing quality of care at the institution, they are primarily
free text, which allows substantial variation in documen-
tation of the care provided. Data were acquired from
the demographic information, diagnosis codes, patient
problem list, pharmacy, laboratory, inpatient, and outpa-
tient components of the medical record. These data
were entered into a specially designed chart abstraction
form, and entered into a spreadsheet and exported to
SPSS (Version 17.0, Chicago, IL) for subsequent analysis.
This study was approved by the Institutional Review
Board of the Medical Center.
Sample
Eligible participants received care at the medical center,
were at least 18 years of age, able to speak English and,
due to an additional component of the larger study,
were able to complete a telephone interview. Probable
epilepsy patients were identified by searching the elec-
tronic medical record system for all patients who had at
least one ICD-9 code of 345.x or 780.39, or mention of
the terms “epilepsy” or “seizure disorder” in the medical
record problem list between 2004 and 2007. In order to
assure there would be adequate data to assess the qual-
ity of epilepsy care we further required that individuals
h a v et w oo rm o r ev i s i t st ot h ep r i m a r yc a r eo rn e u r o l -
ogy clinics, or one visit to the primary care or neurology
clinic and at least one hospitalization [17] between 2004
and 2007.
Individuals identified as eligible for the study based on
diagnosis of epilepsy and who were confirmed to have
epilepsy by their primary care provider or neurologist
and received a letter from their physician informing
them about the study and inviting their participation.
Chart abstractions examining the quality of epilepsy
care were completed by trained clinical chart abstractors
only for those participants who contacted the study
team after receiving the letter and provided written
consent to participate in the study.
Quality Indicators
QUIET quality indicators were developed using the
RAND appropriateness method-a process that integrates
as y s t e m i cl i t e r a t u r er e v i e ww i t ha ne x p e r tc o n s e n s u s
process to identify items that are considered appropriate
and feasible measures of quality healthcare. Since exist-
ing evidence based guidelines from international sources
existed, we adapted some items from those existing
guidelines (e.g,, National Institute for Clinical Excellence
[NICE] and Scottish Intercollegiate Guidelines Network
[SIGN]), for use in the US healthcare setting [8,9].
Other items were developed using systematic literature
review. A panel of 10 epilepsy experts and 1 primary
care provider completed three rounds of ratings to iden-
tify items for which there was consensus regarding
appropriateness, feasibility and necessity. Additional file
1s h o w st h eQ I ’s that were rated appropriate and feasi-
ble indicators of epilepsy care quality, and further iden-
tifies QI’s that were adapted from the NICE or SIGN
guidelines, and items which are parallel to measures
included in the Quality and Outcomes Framework mea-
sure used in the United Kingdom [18]. Additional detail
about this process is provided elsewhere [19].
Because of the large number of individual evidence-
based QI’s during the development of the quality mea-
sures, we categorized the 22 QI’si n t of o u ra s p e c t so f
epilepsy care: First Seizure Assessment (3 QI’s), Initial
Epilepsy Treatment (7 QI’s), Chronic Epilepsy Care
(9 QI’s), and Aspects of Care Unique to Women
(3 QI’s). Additional file 1 shows specific QI’s for each
aspect of care.
Operational definitions of quality indicators
Prior to chart abstraction, the research team consisting
of physicians, nurses and health services researchers
with expertise in conducting chart abstractions created
operational definitions that identified specific data ele-
ments that would be used to score each QI. These defi-
nitions were then used to determine if applicable
conditions were present for measuring each QI (i.e. the
IF portion of the quality indicator), and then whether
the process of care defined by the quality indicator was
provided (i.e. the THEN portion). For example: IF the
patient is diagnosed with a seizure disorder/epilepsy and
started on therapy (denominator) THEN the patient
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there was variation in the denominator by QI. While
some QI’s focused on a single visit (at the time of the
first seizure), most QI’s examined the construct in ques-
tion over time. For instance, a number of QI’sr e c o m -
mended that a certain type of care be provided on a
yearly basis (e.g. yearly depression screening). For these,
we assessed visits within the designated time frame.
Thus, our analysis is at the patient level for each QI,
and the total number of individuals who met criteria for
each QI was unique.
A specially designed chart abstraction instrument was
developed, and data regarding processes of care pro-
vided was collected and entered using Microsoft Access.
Research assistants with clinical background were speci-
fically trained to perform chart reviews (Additional file
2). The final chart abstraction instrument was subjected
to multiple layers of review by the research team. Initi-
ally, 25 charts were reviewed by two raters to assess
concordance. Comparison of ratings for the quality indi-
cators in those charts found that raters agreed 76% of
the time. After finalization of the instrument, a second
review of 25 charts conducted by independent raters
found that there was agreement on 86% of ratings.
Initial assessment of concordance between QI’sa n d
care provided used an all-or- nothing approach: if all
aspects of care were performed, the patient received a
positive score for that indicator unless the indicator spe-
cifically stated that one of several aspects of care would
fulfill the requirement (e.g. QI15; see Additional file 1).
However, we also examined the proportion of recom-
mended processes of care completed for each of the
four aspects of epilepsy care described above.
Patient Characteristics
Demographic characteristics including age, sex, race/eth-
nicity, marital status, and education were abstracted
from the electronic medical record. Epilepsy history
(new-onset vs. chronic care), type of seizure (if docu-
mented), and medication information was ascertained
based on longitudinal review of medical records and
intake history for patients new to the medical center.
Finally, the presence of continued seizures was identified
by documentation of seizures in the medical record dur-
ing the study period.
Setting of Epilepsy Care
Epilepsy care was identified by review of outpatient pro-
gress notes that described epilepsy and epilepsy care.
For each epilepsy-focused medical encounter (encounter
in which progress notes mentioned epilepsy) within the
healthcare system, the type of provider was defined as
being a primary care provider (general internist, family
practitioner, or nurse practitioner), neurologist, or other
specialty care. Individuals who received care only within
primary care or neurology settings were classified as
such. Those receiving epilepsy care in both settings
were classified as receiving shared care.
Analysis
We first describe the variation in concordance among
individual QI’s (i.e., the concordance between the
recommended and actual care received), followed by
examination of the proportion of patients who received
the care outlined for each aspect of epilepsy care (First
Seizure, Initial Epilepsy Treatment, Chronic Care,
Aspects of Care Unique to Women; Additional file 1
shows indicators included in each aspect of care). This
analysis was conducted at the patient level, but included
all recommended aspects of care for which each patient
was eligible based on the individual indicators in each
aspect of epilepsy care. This process is described in
more detail below. Finally, we examine receipt of care
by the setting of epilepsy care received using the chi
square statistic. Haberman’s adjusted residual statistic
was used to identify significant cells within the
chi-square analysis [20]. SPSS
® version 17 (Chicago, IL,
USA) was used to conduct data analysis.
Results
The sample for this study consisted of 311 individuals.
Table 1 shows demographics for the sample overall and
by source of care. Overall, approximately 58% were
women, 62% were between 18 and 49 years of age; the
sample was racially diverse with similar numbers of
whites and African Americans. Over half had some col-
lege or a college degree. With regard to epilepsy,
approximately 21% had new-onset epilepsy (within the
past two years) and the median number of antiepileptic
drugs (AEDs) prescribed at the last visit for this sample
was 1 (mean = 1.41, SD = .90). Forty seven percent con-
tinued to have seizures during the study period, and
6 6 %h a dn oc h a n g ei nA E Dd u r i n gt h ec o u r s eo ft h e
study. Examination of demographic characteristics
(Table 1) by source of care found that African Ameri-
cans were more likely to be in shared care and primary
care groups and less likely to be in the neurology group
than expected (X
2 =1 8 . 8 ,d f=2 ;p<0 . 0 1 ) .I n d i v i d u a l s
with continued seizures were less likely to be the pri-
mary care group and more likely to receive shared care
than expected by chance (X
2 = 21.5, df = 2; p < 0.01).
Individuals within the primary care group were less
likely to have a medication change over the course
of the study than expected by chance (X
2 =9 . 6 ,d f=2 ;
p = 0.01).
There was substantial variation in concordance
between recommended care and actual care for indivi-
dual QI’s (Table 2). Excluding indicators with a total
Pugh et al. BMC Health Services Research 2011, 11:1
http://www.biomedcentral.com/1472-6963/11/1
Page 3 of 9denominator of less than 25 (to ensure precision of ana-
lyses) concordance ranged from 2% for QI16 to 99% for
QI’s 15 and 18. The mean proportion of concordant
care by indicator was 54.0 (standard deviation = 28.0);
the median was 59.26.
Table 2 shows the proportion of patients who received
QI concordant care for each QI overall and by the set-
ting of epilepsy care. The only QI’s where sufficient pri-
mary care patients were represented for the purposes of
analysis were in chronic epilepsy care: QI 14, 15 16, 20,
21, and 23. For these aspects of chronic epilepsy care
we found no statistically significant differences in the
extent to which patients received referral for treatment
after a positive depression screen (QI 21; X
2 = 0.73,
df = 2; p = 0.7), or folate supplementation for women of
childbearing age (QI 23: X
2 = 3.6, df = 2; p = 0.2) by
the setting of epilepsy care. Haberman’sA d j u s t e dR e s i -
dual analysis of statistically significant analyses indicated
that patients who received primary care were less likely
than expected to have documentation of approximate
seizure count since their last visit (QI 14; X
2 =1 3 . 6 ,d f
=2 ;p=0 . 0 0 1 )o ri n t e r v e n t i o n sp e r f o r m e di nl i g h to f
continued seizures documentation of patient education
(QI 15: X
2 = 47.6, df = 2; p < 0.001). Individuals who
received care in neurology and primary care settings
were less likely to receive depression screening than
those who received shared care (QI 20 X
2 =6 . 2 ,d f=2 ;
26.21; p < 0.001).
Table 3 shows the proportion of QI concordant care
among the four aspects of epilepsy care (first seizure
evaluation, initial epilepsy treatment, chronic epilepsy
care, and aspects of care unique to women) overall and
by setting of epilepsy care. The number reported in
each column represents the proportion of all possible
care processes that were performed among the care pro-
cesses outlined by the QI for those who met QI inclu-
sion criteria. For evaluation of a first seizure, of the 65
individuals who received a first seizure evaluation there
were 151 possible opportunities for care among indivi-
duals who met inclusion criteria regarding QI’s for first
seizure assessment (QI 1-3). Of those 151 opportunities
for QI concordant care, 64 were completed (42.38%).
Among the 65 individuals who met criteria for QI’s
examining initial treatment of epilepsy, there were 297
Table 1 Characteristics of Study Participants
All Neurology Only N (%) Shared care N (%) Primary Care Only N (%)
Total 311 203 (65.27) 77 (24.76) 31 (9.97)
Sex
Female 181 (58.20) 114 (56.16) 50 (64.94) 17 (54.84)
Male 130 (41.80) 89 (43.84) 27 (35.06) 14 (45.16)
Age
18-49 194 (62.38) 131 (64.53) 46 (59.74) 17 (54.84)
50-64 80 (25.72) 46 (22.66) 24 (31.17) 10 (32.26)
65+ 37 (11.90) 26 (12.81) 7 (9.09) 4 (12.90)
Race/Ethnicity
White 147 (47.27) 112 (55.17)* 27 (35.06)* 8 (25.81)*
African American 133 (42.77) 70 (34.48)* 42 (54.55)* 21 (67.74)*
Other 31 (9.97) 21 (10.34) 8 (10.39) 2 (6.45)
Education
Less than high school 50 (16.29) 28 (13.86) 13 (17.33) 9 (30.00)
High school graduate 91 (29.64) 63 (31.19) 23 (30.67) 5 (16.67)
Some college 93 (30.29) 57 (28.22) 23 (30.67) 13 (43.33)
College graduate 73 (23.78) 54 (26.73) 16 (21.33) 3 (10.00)
New-Onset Epilepsy 65 (20.90) 45 (21.17) 16 (20.78) 4 (12.90)
Number of Epilepsy Medications
(Last clinic visit)
0 32 (10.29) 19 (9.36) 7 (9.09) 6 (19.35)
1 166 (53.38) 109 (53.69) 41 (53.25) 16 (51.61)
2 76 (24.44) 51 (25.12) 19 (24.68) 6 (19.35)
3 or more 37 (11.90) 24 (11.83) 10 (12.99) 3 (9.68)
No Antiepileptic Drug Change 207 (65.56) 133 (65.52) 46 (59.74) 28 (90.32)
Continued seizures 147 (47.27) 90 (44.33)* 51 (66.23) 6 (19.35)*
Education is self-reported
*p < 0.01.
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care was provided for 131 (44.11%) of those opportu-
nities. Among the 311 individuals who met criteria for
many of the chronic epilepsy care QI’s, there were 1,409
opportunities for recommended care; 45.07% of the time
QI concordant care was provided. Among the 111
women of child-bearing age included in the study there
were 128 opportunities for recommended care; 36.72%
o ft h et i m eQ Ic o n c o r d a n tc a r ew a sp r o v i d e d .T h e s e
data indicate that overall, less than half of all possible
QI identified care processes (877/1985; 44.2%) were
completed in this sample. The lowest concordance
between recommended care and actual care was for
aspects of care unique to women.
Further examination of quality within each aspect of
epilepsy care suggests that there were also significant
differences by the setting in which care was received.
Our examination of differences between settings of care
was restricted to neurology vs. shared care for First
Seizure Assessment and Aspects of Care Unique to
Table 2 Proportion of Patients Receiving QI Concordant Care by Setting of Care
Quality Indicator All N = 311 Neurology only N = 203 Shared care N = 77 Primary Care Only N = 31
Evaluation of First Seizure
QI 1. 22/65 = 33.85% 11/45 = 24.44% 10/16 = 62.5% 1/4 = 25%
QI 2. 25/65 = 38.46% 18/45 = 40% 7/16 = 43.75% 0/4 = 0%
QI 3. 17/21 = 80.95% 12/16 = 75% 3/3 = 100% 2/2 = 100%
Initial Treatment of Epilepsy
QI 4. 29/65 = 44.62% 21/45 = 46.67% 8/16 = 50% 0/4 = 0%
QI 5. 10/65 = 15.38% 5/45 = 11.11% 4/16 = 25% 1/4 = 25%
QI 6. 34/46 = 73.91% 23/31 = 74.19% 10/11 = 90.91% 1/4 = 25%
QI 7. 21/23 = 91.3% 15/15 = 100% 6/6 = 100% 0/2 = 0%
QI 8. 17/64 = 26.56% 12/44 = 27.27% 5/16 = 31.25% 0/4 = 0%
QI 9. NA NA NA NA
QI 11. 20/31 = 64.52% 12/21 = 57.14% 7/9 = 77.78% 1/1 = 100%
Follow-up/Chronic Disease Care
QI 14. 76/272 = 27.94% 53/176 = 30.11% 23/66 = 34.85% 0/30 = 0%
QI 15. 145/147 = 98.64% 90/90 = 100% 51/51 = 100% 4/6 = 66.67%
QI 16 6/311 = 1.93% 2/203 = 0.99% 4/77 = 5.19% 0/31 = 0%
QI 17. 16/27 = 59.26% 12/19 = 63.16% 4/8 = 50%
QI 18. 69/70 = 98.57% 43/43 = 100% 26/27 = 96.3%
QI 19. 82/132 = 62.12% 50/83 = 60.24% 30/46 = 65.22% 2/3 = 66.67%
QI 20. 142/311 = 45.66% 72/203 = 35.47% 53/77 = 68.83% 17/31 = 54.84%
QI 21. 88/125 = 70.4% 53/73 = 72.6% 22/34 = 64.71% 13/18 = 72.22%
QI 22. 11/14 = 78.57% 6/7 = 85.71% 5/7 = 71.43%
Aspects of Care Specific to Women
QI 23. I 38/111 = 34.23% 24/73 = 32.88% 13/29 = 44.83% 1/9 = 11.11%
QI 24. 1/5 = 20% 0/2 = 0% 1/3 = 33.33%
QI 25. 8/12 = 66.67% 3/6 = 50% 5/5 = 100%
QI number is based on the original QI’s reported in Pugh MJ, Berlowitz DR, Montouris G et al. What constitutes high quality of care for adults with epilepsy?
Neurology 2007; 69(21):2020-7. QI were not deemed appropriate and necessary (QI 10, 12, 13) are not presented in this paper.
Table 3 Proportion of all Possible Opportunities Taken for Quality Epilepsy Care by Setting of Epilepsy Care
Aspect of Epilepsy Care N*** All Neurology Only Shared care Primary Care Only
First seizure assessment
$ 63 64/151 = 42.38% 41/106 = 38.70% 20/35 = 57.14% 3/10 = 30.00%
Initial epilepsy treatment 63 131/297 = 44.11% 88/203 = 43.35% 40/75 = 53.33% 3/19 = 15.79%
Chronic epilepsy care 302 635/1409 = 45.07% 381/897 = 42.47% 218/393 = 55.47% 36/119 = 30.25%
Aspects of care unique to women
$ 108 47/128 = 36.72% 27/81 = 33.33% 19/37 = 51.35% 1/10 = 10.00%
$ Insufficient N for Primary Care Only; unable to compare.
* p < 0.05.
**p < .01.
***N that could potentially qualify for inclusion in analysis if all inclusion criteria for a specific quality indicator are met.
The numerator in each column represents the number of possible care processes that were performed; the denominator represents the number of possible care
processes. For specific numbers of patients, and specific indicators included in each aspect of epilepsy care please refer to Table 2.
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Care Only. For First Seizure Assessment, we found a trend
approaching significance with individuals receiving shared
care having more aspects of QI concordant care per-
formed than did those receiving care in a neurology set-
ting (Table 3; X
2 = 3.7; p = 0.06). For Initial Epilepsy
Treatment concordance by setting of care varied from
16% for those receiving primary care only to 53% for those
receiving shared care; individuals receiving primary care
were significantly less likely to receive QI concordant care
than expected (X
2 = 9.0; p = 0.01). Concordance for QI’s
included in Chronic Epilepsy Care ranged from 30% for
those receiving primary care only to 55% for those receiv-
ing shared care. Individuals receiving shared care were
more likely to receive QI concordant care than those
receiving neurology or primary care (X
2 = 30.2; p < 0.001).
For Aspects of Care Unique to Women, there was a trend
approaching significance, with individuals receiving shared
care being more likely to receive QI concordant care than
those receiving neurology care (X
2 =3 . 5 ;p=0 . 0 6 ) .
Discussion
This study used data from electronic medical records to
assess the extent to which patients with epilepsy receive
processes of epilepsy care identified as QI’s designed for
use in primary and general neurology care. We were
able to reliably assess the extent to which recommended
care was documented in patient records. However find-
ings for several indicators where fewer than 5% of the
sample received recommended aspects of care suggest
additional evaluation of those indicators or data sources
is needed.
Consistent with studies examining QI concordant care
in other chronic diseases, less than half of all possible
care processes were completed [21]. There was wide var-
iation in the extent to which all recommended processes
of care were provided, with Aspects of Care Unique to
Women having the lowest rates of concordance.
Our data provide limited support for our hypothesis
that individuals receiving shared care have better quality
of care than individuals receiving only primary care or
o n l yn e u r o l o g ys u b s p e c i a l t yc a r e .T h eo n l yQ I ’sf o r
which there were significant differences between
patients receiving neurology care and those shared care
was QI20 which suggests that persons with epilepsy
should receive an annual depression assessment. Our
data do not indicate who conducted the depression
assessment. It is possible that the neurologist was more
likely to attend to these items immediately for a patient
that would be seen only once for referral, than the more
complex patients with competing demands who were
seen continuously in neurology settings [22]. The more
complex patients who were seen exclusively in neurol-
ogy settings likely had acute issues associated with their
seizures that required immediate attention, leaving little
or no time at the end of an office visit to address
chronic disease management issues. Alternatively, these
chronic disease management issues may have also been
addressed by the neurologist but not documented due
to the intensive documentation required to address
more acute seizure care.
Further examination of the aggregate measures where
there is more power to detect differences between indi-
viduals receiving shared vs. primary or neurology care
only, our analysis revealed that there was a significant
difference between shared care and neurology only care
only for chronic disease management.
Shared care has been examined in a variety of con-
texts with mixed results. A number of studies have
found no difference in quality for patients in shared care
compared to those in specialtyc a r ee x c l u s i v e l y[ 2 3 , 2 4 ] .
Rosendal and colleagues found that individuals with hip
fracture and receiving shared care had more home care
after discharge, and lower scores on the short version of
the Sickness Impact Profile indicating improved recov-
ery [25]. Pugh and colleagues found that patients with
diabetes were more likely to receive guideline concor-
dant diabetes medications if they received care from
both primary and specialty care compared to primary
care or specialty care exclusively [26].
Our analysis suggests that, for epilepsy, QI’s associated
with types of care that are more technical in nature (e.
g., QI 2, 7, 15, 18) tended to have higher rates of con-
cordance, while those associated with discussion, patient
education, and chronic disease management (e.g., QI 5,
8, 16) tended to have lower rates of concordance. It is
possible that these aspects of patient care that are more
interpersonally oriented were actually performed, but
not documented. However, documentation of these
aspects of care is in and of itself an indicator of quality.
Because several of these interpersonally oriented items
are ones included in the UK’s Quality and Outcomes
framework, there is broad international consensus that
they are critical components of the quality of epilepsy
care (e.g., particularly documenting seizure frequency
and reviewing medication management). Accordingly
the QUIET indicators could be used to develop electro-
nic templates for use in documenting care for patients
with epilepsy in organizations with electronic medical
records (or a paper template for settings with paper
records). Such a template would facilitate documenta-
tion of these important processes of care when they
occur, and guide providers who do not commonly pro-
vide care for patients with epilepsy.
Beyond our hypothesis, we found that chronic disease
management issues specific to women tended to have
lower rates of concordance than other aspects of
care. Again, it is possible that women were taking over-
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mended dose of folate and did not need a prescription.
However, the drug-drug interaction between lamotrigine
and oral contraceptives was not addressed in four of five
eligible patients. Because the numbers of women meet-
ing criteria was low for QI 24 women’s issues should be
highlighted as a concern not only for clinicians
to address, but also as a concern requiring additional
quality assessment.
Finally, our findings suggest that issues recently high-
lighted in the literature-bone health and mood disorders
[27,28] -are being addressed for many patients with epi-
lepsy. Approximately 62% of individuals on AEDs for
two or more years received testing for Vitamin D or a
DXA scan. With regard to mood disorders, 46% received
recommended screening. Of t h o s ew i t he v i d e n c eo f
anxiety or depression, 71% received treatment with
medications or a referral to a mental health practitioner.
These findings must be interpreted in light of several
limitations. First, this study was in a single medical center
in which study participants appeared to have higher rates
of uncontrolled seizures than estimates from the litera-
ture [29]. The complexity of these patients may be such
that competing demands for physician time make addres-
sing less acute issues more difficult, so these findings may
not reflect the quality of care provided for less compli-
cated patients. Attempts to adjust these results for dis-
ease severity, however, did not change results since there
were no significant differences in QI concordant care for
those with and without continued seizures. This limited
sample, from a single geographic location provides a
point of reference for future studies from other geo-
graphic regions and multi-site studies with power to
detect geographic variations in care that may exist.
Related to this single-site study is the fact that the
total number of patients (N = 311) was relatively small,
particularly after stratifying patients into groups of neu-
rology care, shared care and primary care. The primary
care group was particularly small for all groups except
chronic epilepsy care. Thus, findings for the primary
care group must be interpreted with caution.
Next, quality of care was assessed primarily using the
electronic medical record. As described above, it is pos-
sible that interpersonal aspects of care were addressed
but not documented. A number of aspects of care that
are more interpersonal in nature may be better assessed
using patient reported survey measures. Future studies
examining the quality of epilepsy care using a broad
measure such as the QUIET indicators may benefit
from an approach that utilizes not only medical chart
abstraction, but a targeted survey that provides a second
assessment of patient reported receipt of care which
allows one to triangulate data to assess the care received
by patients. Moreover, such a survey would benefit by
adding quality of life measures, and other potential out-
comes that may be linked to higher quality care such as
employment, relationship status, and education.
We further found that scoring compound QI’s (e.g., 1,
8 and 16) in an all or nothing fashion may lead to loss
of useful information. Adaptation and/or disaggregation
of specific aspects of these QI’s may be needed in future
research on the quality of epilepsy care. However, our
assessment of broad areas of epilepsy care (Table 3)
examined the proportion of possible care processes that
were completed. Even in this analysis where credit was
given for completing even one aspect of care for com-
plex QI’s, fewer than half of all possible processes of
care were completed, suggesting room for improvement
in all aspects of epilepsy care.
Finally, because these QI’s were designed for use in
primary or general neurology care settings, it is possible
that some very important aspects of care may not be as
clearly articulated. For instance we indicated numerous
points where referral to a higher level of specialty care
is recommended. Due to the structure of care in the US,
we did not specifically identify a point in time where a
patient should be referred to a tertiary epilepsy center
for comprehensive evaluation. This limitation should be
addressed by future versions of this measure.
Conclusion
This study provides a snapshot of the quality of care
provided to adults with epilepsy in one metropolitan
healthcare system. While results are only from a single
hospital, these findings suggest that assessment of qual-
ity using most of the QUIET QI’s is feasible, and that
care for epilepsy can in large part be reliably measured
using medical chart abstraction. This tool will allow
identification of gaps in quality for epilepsy care within
other healthcare systems, and eventually it can be used
to improve the care provided for adults with epilepsy.
However additional evaluation of the QUIET measure
using patient surveys and development of QI’s for use in
specialty care is also needed.
Additional material
Additional file 1: Quality in epilepsy treatment in adults (QUIET)
indicators. This file includes the specific quality indicators included in
the QUIET measure.
Additional file 2: CDC epilepsy quality of care study: patients’
medical record review/abstraction form. This file includes the chart
abstraction form used to collect data on quality of care from patients’
electronic medical record.
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